Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10086068 Peanut formulations and uses thereof

Patent 10086068 was granted and assigned to Aimmune Therapeutics on October, 2018 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Aimmune Therapeutics

0

Current Assignee

Aimmune Therapeutics

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Howard V. Raff0

Bryan Walser0

Date of Patent

October 2, 2018

0

Patent Application Number

152764400

Date Filed

September 26, 2016

0

Patent Citations Received

US Patent 12016917 Peanut formulations and uses thereof

0

US Patent 10512686 Peanut formulations and used thereof

0

US Patent 10653773 Peanut formulations and uses thereof

US Patent 10918676 Egg protein formulations and methods of manufacture thereof

US Patent 11369676 Methods of oral immunotherapy

US Patent 11406563 Oral immunotherapy unit dose dispensing systems and methods

US Patent 11229673 Methods for improving the quality of life of a patient with a peanut allergy

US Patent 10449118 Manufacture of peanut formulations for oral desensitization

Patent Primary Examiner

0

Patent abstract

The present application relates to compositions for oral immunotherapy of peanut allergies. Further, the present application relates to methods for the preparation of the compositions for immunotherapy, and their use in immunotherapy.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10086068 Peanut formulations and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool